Asset One Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.18M Buy
21,235
+1,453
+7% +$313K 0.55% 49
2026
Q1
$4.06M Buy
19,782
+765
+4% +$170K 0.45% 59
2025
Q4
$4.29M Buy
+19,017
New +$4.33M 0.59% 41

Other funds holding ABBV

Asset One Wealth Management's ABBV Position: Q2 2026 in Review

Asset One Wealth Management increased its AbbVie (ABBV) stake by 7.3% in Q2 2026, buying an estimated $313K and bringing the position to 21,235 shares worth $5.18M. The position accounts for 0.55% of the portfolio, ranked #49.

Asset One Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Asset One Wealth Management held 21,235 shares of AbbVie worth $5.18M as of Q2 2026.
  • Asset One Wealth Management bought 1,453 AbbVie shares in Q2 2026, an estimated $313K.
  • AbbVie made up 0.55% of Asset One Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Asset One Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Asset One Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.